Informations for shareholders

Basic informations

The company is operating under the name Bioceltix (registered EU trademark). The company is operating in the form of a joint-stock company.

The company has its registered office at Eugeniusza Kwiatkowskiego 4 Str., 52-326 Wrocław, Poland.  The Research and Development Centre is located at Bierutowska 57-59 Str., 51-317 Wrocław, Poland.

The company is registered in the Register of Entrepreneurs of the National Court Register under KRS number 0000744521, District Court for Wrocław-Fabryczna in Wroclaw, VI Commercial Division of the National Court Register.

The statutory capital of the company amounts to PLN 243.460,80, paid in statutory capital amounts to PLN 243.460,80.

Tax identification number (NIP): PL899-27-94-360.

Statistical number (REGON): 364963245.

The quantity of all shares totals to 2.434.608, including series A shares in the amount of 2.434.608, series B shares in the amount of 104.290, series C shares in the amount of 172.000, series D shares in the amount of 176.818. The company’s shares are not privileged.

 

Shareholders structure:

Notifications for shareholders

The Management Board of Bioceltix JSC informs, that on March 3, 2020 the information was received about the registration on February 27, 2020 in the National Court Register by the District Court for Wrocław-Fabryczna in Wrocław, VI Commercial Department of the National Court Register, of increase in the statutory capital of Bioceltix S.A. from PLN 233.499,00 to PLN 243.460,80 in connection with the additional issue of series D shares within the authorized capital. Due to the change, the number of registered series D shares increased from 77.200 to 176.818 shares.